Seres Therapeutics, Inc. (1S90)
Market Closed
1 Sep, 20:00
XFRA 
€
4. 15
-0.03
-0.7177%
€
61.49M Market Cap
- P/E Ratio
- Div Yield
50 Volume
-0.99 Eps
€ 4.18
Previous Close Want to track 1S90 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Seres Therapeutics, Inc. (1S90) Statistics
Valuation metrics
Market Cap 61.49M
Enterprise value 95.26M
Trailing P/E (ttm) 11.44
Forward P/E -
PEG ratio -0.07
Price/Sales (ttm) 52.6
Price/Book (mrq) 2.62
Enterprise Value/Revenue 96.77
Enterprise Value/EBITDA -1.32
Overview
Shares outstanding 9.59M
Float 7.37M
Shares short -
% Held by insiders 0.12%
% Held by institutions 0.24%
Average volume (10 days) 21
Average volume (90 days) 20
Price summary
52-Week low 3.65
52-Week high 25.9
Beta 0.12
50-Day moving average 7.09
200-Day moving average 11.86
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:20
Last split Date 22 Apr 2025
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Mar 2026
Profitability
Profit margin -7.29%
Operating margin -58.4%
Operational effectiveness
Return on assets -0.39%
Return on equity -1.22%
Income Statement
Revenue (ttm) 984.4K
Revenue per share (ttm) 0.13
Quarterly revenue growth (yoy) -0.55%
Gross profit (ttm) -44.89M
EBITDA -71.92M
Net income to common (ttm) -40.25M
Diluted EPS (ttm) -4.48
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) 25.6M
Total cash per share (mrq) 3.08
Total debt (mrq) 69.09M
Total Debt/Equity (mrq) 303.78
Current ratio (mrq) 1.65%
Book value per share (mrq) 2.38
Cash Flow
Cash flow statement -36.18M
Levered free cash flow (LFCF) -35.65M
